KEGG   DRUG: Tick-borne encephalitis vaccine
Entry
D12206                      Drug                                   
Name
Tick-borne encephalitis vaccine;
Ticovac (TN)
Product
TICOVAC (Pfizer Laboratories Div Pfizer)
Remark
Therapeutic category: 6313
ATC code: J07BA01
Product: D12206<JP/US>
Efficacy
Active immunization (tick-borne encephalitis virus)
  Disease
Tick-borne encephalitis [DS:H00380]
Comment
Prepared from tick-borne encephalitis (TBE) virus propagated in chick embryo fibroblast cells.
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07B VIRAL VACCINES
    J07BA Encephalitis vaccines
     J07BA01 Encephalitis, tick borne, inactivated, whole virus
      D12206  Tick-borne encephalitis vaccine <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6313  Viral vaccines
     D12206  Tick-borne encephalitis vaccine
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12206
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D12206
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12206

» Japanese version   » Back

  All links  
Ontology (5)   
   KEGG BRITE (5)   
Disease (1)   
   KEGG DISEASE (1)   
All databases (6)   

Download RDF
DBGET integrated database retrieval system